Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
I have appreciated the support from my manager, leadership and team. The environment at KPTI is fast paced with opportunity to innovate and try new things - with a priority and focus on people and patients first.
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Teamwork and support from my KPTI colleagues
O que faz você mais feliz no trabalho?
Being a resource and cross functional partner to my KPTI colleagues and leadership.
Quais são algumas das melhores coisas da sua equipe?
We are one team. Everyone supports each other regardless of their role or function. This allows us to achieve our goals and objectives.
Other Employee Reviews for Karyopharm Therapeutics
×